A New Screening Method for the Directed Evolution of Thermostable Bacteriolytic Enzymes

Directed evolution is defined as a method to harness natural selection in order to engineer proteins to acquire particular properties that are not associated with the protein in nature. Literature has provided numerous examples regarding the implementation of directed evolution to successfully alter...

Full description

Saved in:
Bibliographic Details
Published inJournal of visualized experiments no. 69
Main Authors Heselpoth, Ryan D., Nelson, Daniel C.
Format Journal Article
LanguageEnglish
Published United States MyJove Corporation 07.11.2012
Subjects
Online AccessGet full text
ISSN1940-087X
1940-087X
DOI10.3791/4216

Cover

Loading…
Abstract Directed evolution is defined as a method to harness natural selection in order to engineer proteins to acquire particular properties that are not associated with the protein in nature. Literature has provided numerous examples regarding the implementation of directed evolution to successfully alter molecular specificity and catalysis(1). The primary advantage of utilizing directed evolution instead of more rational-based approaches for molecular engineering relates to the volume and diversity of variants that can be screened(2). One possible application of directed evolution involves improving structural stability of bacteriolytic enzymes, such as endolysins. Bacteriophage encode and express endolysins to hydrolyze a critical covalent bond in the peptidoglycan (i.e. cell wall) of bacteria, resulting in host cell lysis and liberation of progeny virions. Notably, these enzymes possess the ability to extrinsically induce lysis to susceptible bacteria in the absence of phage and furthermore have been validated both in vitro and in vivo for their therapeutic potential(3-5). The subject of our directed evolution study involves the PlyC endolysin, which is composed of PlyCA and PlyCB subunits(6). When purified and added extrinsically, the PlyC holoenzyme lyses group A streptococci (GAS) as well as other streptococcal groups in a matter of seconds and furthermore has been validated in vivo against GAS(7). Significantly, monitoring residual enzyme kinetics after elevated temperature incubation provides distinct evidence that PlyC loses lytic activity abruptly at 45 °C, suggesting a short therapeutic shelf life, which may limit additional development of this enzyme. Further studies reveal the lack of thermal stability is only observed for the PlyCA subunit, whereas the PlyCB subunit is stable up to ~90 °C (unpublished observation). In addition to PlyC, there are several examples in literature that describe the thermolabile nature of endolysins. For example, the Staphylococcus aureus endolysin LysK and Streptococcus pneumoniae endolysins Cpl-1 and Pal lose activity spontaneously at 42 °C, 43.5 °C and 50.2 °C, respectively(8-10). According to the Arrhenius equation, which relates the rate of a chemical reaction to the temperature present in the particular system, an increase in thermostability will correlate with an increase in shelf life expectancy(11). Toward this end, directed evolution has been shown to be a useful tool for altering the thermal activity of various molecules in nature, but never has this particular technology been exploited successfully for the study of bacteriolytic enzymes. Likewise, successful accounts of progressing the structural stability of this particular class of antimicrobials altogether are nonexistent. In this video, we employ a novel methodology that uses an error-prone DNA polymerase followed by an optimized screening process using a 96 well microtiter plate format to identify mutations to the PlyCA subunit of the PlyC streptococcal endolysin that correlate to an increase in enzyme kinetic stability (Figure 1). Results after just one round of random mutagenesis suggest the methodology is generating PlyC variants that retain more than twice the residual activity when compared to wild-type (WT) PlyC after elevated temperature treatment.
AbstractList Directed evolution is defined as a method to harness natural selection in order to engineer proteins to acquire particular properties that are not associated with the protein in nature. Literature has provided numerous examples regarding the implementation of directed evolution to successfully alter molecular specificity and catalysis1. The primary advantage of utilizing directed evolution instead of more rational-based approaches for molecular engineering relates to the volume and diversity of variants that can be screened2. One possible application of directed evolution involves improving structural stability of bacteriolytic enzymes, such as endolysins. Bacteriophage encode and express endolysins to hydrolyze a critical covalent bond in the peptidoglycan (i.e. cell wall) of bacteria, resulting in host cell lysis and liberation of progeny virions. Notably, these enzymes possess the ability to extrinsically induce lysis to susceptible bacteria in the absence of phage and furthermore have been validated both in vitro and in vivo for their therapeutic potential3-5. The subject of our directed evolution study involves the PlyC endolysin, which is composed of PlyCA and PlyCB subunits6. When purified and added extrinsically, the PlyC holoenzyme lyses group A streptococci (GAS) as well as other streptococcal groups in a matter of seconds and furthermore has been validated in vivo against GAS7. Significantly, monitoring residual enzyme kinetics after elevated temperature incubation provides distinct evidence that PlyC loses lytic activity abruptly at 45 °C, suggesting a short therapeutic shelf life, which may limit additional development of this enzyme. Further studies reveal the lack of thermal stability is only observed for the PlyCA subunit, whereas the PlyCB subunit is stable up to ~90 °C (unpublished observation). In addition to PlyC, there are several examples in literature that describe the thermolabile nature of endolysins. For example, the Staphylococcus aureus endolysin LysK and Streptococcus pneumoniae endolysins Cpl-1 and Pal lose activity spontaneously at 42 °C, 43.5 °C and 50.2 °C, respectively8-10. According to the Arrhenius equation, which relates the rate of a chemical reaction to the temperature present in the particular system, an increase in thermostability will correlate with an increase in shelf life expectancy11. Toward this end, directed evolution has been shown to be a useful tool for altering the thermal activity of various molecules in nature, but never has this particular technology been exploited successfully for the study of bacteriolytic enzymes. Likewise, successful accounts of progressing the structural stability of this particular class of antimicrobials altogether are nonexistent. In this video, we employ a novel methodology that uses an error-prone DNA polymerase followed by an optimized screening process using a 96 well microtiter plate format to identify mutations to the PlyCA subunit of the PlyC streptococcal endolysin that correlate to an increase in enzyme kinetic stability (Figure 1). Results after just one round of random mutagenesis suggest the methodology is generating PlyC variants that retain more than twice the residual activity when compared to wild-type (WT) PlyC after elevated temperature treatment.
Directed evolution is defined as a method to harness natural selection in order to engineer proteins to acquire particular properties that are not associated with the protein in nature. Literature has provided numerous examples regarding the implementation of directed evolution to successfully alter molecular specificity and catalysis 1 . The primary advantage of utilizing directed evolution instead of more rational-based approaches for molecular engineering relates to the volume and diversity of variants that can be screened 2 . One possible application of directed evolution involves improving structural stability of bacteriolytic enzymes, such as endolysins. Bacteriophage encode and express endolysins to hydrolyze a critical covalent bond in the peptidoglycan ( i.e. cell wall) of bacteria, resulting in host cell lysis and liberation of progeny virions. Notably, these enzymes possess the ability to extrinsically induce lysis to susceptible bacteria in the absence of phage and furthermore have been validated both in vitro and in vivo for their therapeutic potential 3-5 . The subject of our directed evolution study involves the PlyC endolysin, which is composed of PlyCA and PlyCB subunits 6 . When purified and added extrinsically, the PlyC holoenzyme lyses group A streptococci (GAS) as well as other streptococcal groups in a matter of seconds and furthermore has been validated in vivo against GAS 7 . Significantly, monitoring residual enzyme kinetics after elevated temperature incubation provides distinct evidence that PlyC loses lytic activity abruptly at 45 °C, suggesting a short therapeutic shelf life, which may limit additional development of this enzyme. Further studies reveal the lack of thermal stability is only observed for the PlyCA subunit, whereas the PlyCB subunit is stable up to ~90 °C (unpublished observation). In addition to PlyC, there are several examples in literature that describe the thermolabile nature of endolysins. For example, the Staphylococcus aureus endolysin LysK and Streptococcus pneumoniae endolysins Cpl-1 and Pal lose activity spontaneously at 42 °C, 43.5 °C and 50.2 °C, respectively 8-10 . According to the Arrhenius equation, which relates the rate of a chemical reaction to the temperature present in the particular system, an increase in thermostability will correlate with an increase in shelf life expectancy 11 . Toward this end, directed evolution has been shown to be a useful tool for altering the thermal activity of various molecules in nature, but never has this particular technology been exploited successfully for the study of bacteriolytic enzymes. Likewise, successful accounts of progressing the structural stability of this particular class of antimicrobials altogether are nonexistent. In this video, we employ a novel methodology that uses an error-prone DNA polymerase followed by an optimized screening process using a 96 well microtiter plate format to identify mutations to the PlyCA subunit of the PlyC streptococcal endolysin that correlate to an increase in enzyme kinetic stability ( Figure 1 ). Results after just one round of random mutagenesis suggest the methodology is generating PlyC variants that retain more than twice the residual activity when compared to wild-type (WT) PlyC after elevated temperature treatment.
Directed evolution is defined as a method to harness natural selection in order to engineer proteins to acquire particular properties that are not associated with the protein in nature. Literature has provided numerous examples regarding the implementation of directed evolution to successfully alter molecular specificity and catalysis(1). The primary advantage of utilizing directed evolution instead of more rational-based approaches for molecular engineering relates to the volume and diversity of variants that can be screened(2). One possible application of directed evolution involves improving structural stability of bacteriolytic enzymes, such as endolysins. Bacteriophage encode and express endolysins to hydrolyze a critical covalent bond in the peptidoglycan (i.e. cell wall) of bacteria, resulting in host cell lysis and liberation of progeny virions. Notably, these enzymes possess the ability to extrinsically induce lysis to susceptible bacteria in the absence of phage and furthermore have been validated both in vitro and in vivo for their therapeutic potential(3-5). The subject of our directed evolution study involves the PlyC endolysin, which is composed of PlyCA and PlyCB subunits(6). When purified and added extrinsically, the PlyC holoenzyme lyses group A streptococci (GAS) as well as other streptococcal groups in a matter of seconds and furthermore has been validated in vivo against GAS(7). Significantly, monitoring residual enzyme kinetics after elevated temperature incubation provides distinct evidence that PlyC loses lytic activity abruptly at 45 °C, suggesting a short therapeutic shelf life, which may limit additional development of this enzyme. Further studies reveal the lack of thermal stability is only observed for the PlyCA subunit, whereas the PlyCB subunit is stable up to ~90 °C (unpublished observation). In addition to PlyC, there are several examples in literature that describe the thermolabile nature of endolysins. For example, the Staphylococcus aureus endolysin LysK and Streptococcus pneumoniae endolysins Cpl-1 and Pal lose activity spontaneously at 42 °C, 43.5 °C and 50.2 °C, respectively(8-10). According to the Arrhenius equation, which relates the rate of a chemical reaction to the temperature present in the particular system, an increase in thermostability will correlate with an increase in shelf life expectancy(11). Toward this end, directed evolution has been shown to be a useful tool for altering the thermal activity of various molecules in nature, but never has this particular technology been exploited successfully for the study of bacteriolytic enzymes. Likewise, successful accounts of progressing the structural stability of this particular class of antimicrobials altogether are nonexistent. In this video, we employ a novel methodology that uses an error-prone DNA polymerase followed by an optimized screening process using a 96 well microtiter plate format to identify mutations to the PlyCA subunit of the PlyC streptococcal endolysin that correlate to an increase in enzyme kinetic stability (Figure 1). Results after just one round of random mutagenesis suggest the methodology is generating PlyC variants that retain more than twice the residual activity when compared to wild-type (WT) PlyC after elevated temperature treatment.Directed evolution is defined as a method to harness natural selection in order to engineer proteins to acquire particular properties that are not associated with the protein in nature. Literature has provided numerous examples regarding the implementation of directed evolution to successfully alter molecular specificity and catalysis(1). The primary advantage of utilizing directed evolution instead of more rational-based approaches for molecular engineering relates to the volume and diversity of variants that can be screened(2). One possible application of directed evolution involves improving structural stability of bacteriolytic enzymes, such as endolysins. Bacteriophage encode and express endolysins to hydrolyze a critical covalent bond in the peptidoglycan (i.e. cell wall) of bacteria, resulting in host cell lysis and liberation of progeny virions. Notably, these enzymes possess the ability to extrinsically induce lysis to susceptible bacteria in the absence of phage and furthermore have been validated both in vitro and in vivo for their therapeutic potential(3-5). The subject of our directed evolution study involves the PlyC endolysin, which is composed of PlyCA and PlyCB subunits(6). When purified and added extrinsically, the PlyC holoenzyme lyses group A streptococci (GAS) as well as other streptococcal groups in a matter of seconds and furthermore has been validated in vivo against GAS(7). Significantly, monitoring residual enzyme kinetics after elevated temperature incubation provides distinct evidence that PlyC loses lytic activity abruptly at 45 °C, suggesting a short therapeutic shelf life, which may limit additional development of this enzyme. Further studies reveal the lack of thermal stability is only observed for the PlyCA subunit, whereas the PlyCB subunit is stable up to ~90 °C (unpublished observation). In addition to PlyC, there are several examples in literature that describe the thermolabile nature of endolysins. For example, the Staphylococcus aureus endolysin LysK and Streptococcus pneumoniae endolysins Cpl-1 and Pal lose activity spontaneously at 42 °C, 43.5 °C and 50.2 °C, respectively(8-10). According to the Arrhenius equation, which relates the rate of a chemical reaction to the temperature present in the particular system, an increase in thermostability will correlate with an increase in shelf life expectancy(11). Toward this end, directed evolution has been shown to be a useful tool for altering the thermal activity of various molecules in nature, but never has this particular technology been exploited successfully for the study of bacteriolytic enzymes. Likewise, successful accounts of progressing the structural stability of this particular class of antimicrobials altogether are nonexistent. In this video, we employ a novel methodology that uses an error-prone DNA polymerase followed by an optimized screening process using a 96 well microtiter plate format to identify mutations to the PlyCA subunit of the PlyC streptococcal endolysin that correlate to an increase in enzyme kinetic stability (Figure 1). Results after just one round of random mutagenesis suggest the methodology is generating PlyC variants that retain more than twice the residual activity when compared to wild-type (WT) PlyC after elevated temperature treatment.
Directed evolution is defined as a method to harness natural selection in order to engineer proteins to acquire particular properties that are not associated with the protein in nature. Literature has provided numerous examples regarding the implementation of directed evolution to successfully alter molecular specificity and catalysis(1). The primary advantage of utilizing directed evolution instead of more rational-based approaches for molecular engineering relates to the volume and diversity of variants that can be screened(2). One possible application of directed evolution involves improving structural stability of bacteriolytic enzymes, such as endolysins. Bacteriophage encode and express endolysins to hydrolyze a critical covalent bond in the peptidoglycan (i.e. cell wall) of bacteria, resulting in host cell lysis and liberation of progeny virions. Notably, these enzymes possess the ability to extrinsically induce lysis to susceptible bacteria in the absence of phage and furthermore have been validated both in vitro and in vivo for their therapeutic potential(3-5). The subject of our directed evolution study involves the PlyC endolysin, which is composed of PlyCA and PlyCB subunits(6). When purified and added extrinsically, the PlyC holoenzyme lyses group A streptococci (GAS) as well as other streptococcal groups in a matter of seconds and furthermore has been validated in vivo against GAS(7). Significantly, monitoring residual enzyme kinetics after elevated temperature incubation provides distinct evidence that PlyC loses lytic activity abruptly at 45 °C, suggesting a short therapeutic shelf life, which may limit additional development of this enzyme. Further studies reveal the lack of thermal stability is only observed for the PlyCA subunit, whereas the PlyCB subunit is stable up to ~90 °C (unpublished observation). In addition to PlyC, there are several examples in literature that describe the thermolabile nature of endolysins. For example, the Staphylococcus aureus endolysin LysK and Streptococcus pneumoniae endolysins Cpl-1 and Pal lose activity spontaneously at 42 °C, 43.5 °C and 50.2 °C, respectively(8-10). According to the Arrhenius equation, which relates the rate of a chemical reaction to the temperature present in the particular system, an increase in thermostability will correlate with an increase in shelf life expectancy(11). Toward this end, directed evolution has been shown to be a useful tool for altering the thermal activity of various molecules in nature, but never has this particular technology been exploited successfully for the study of bacteriolytic enzymes. Likewise, successful accounts of progressing the structural stability of this particular class of antimicrobials altogether are nonexistent. In this video, we employ a novel methodology that uses an error-prone DNA polymerase followed by an optimized screening process using a 96 well microtiter plate format to identify mutations to the PlyCA subunit of the PlyC streptococcal endolysin that correlate to an increase in enzyme kinetic stability (Figure 1). Results after just one round of random mutagenesis suggest the methodology is generating PlyC variants that retain more than twice the residual activity when compared to wild-type (WT) PlyC after elevated temperature treatment.
Author Heselpoth, Ryan D.
Nelson, Daniel C.
AuthorAffiliation 1 Institute for Bioscience and Biotechnology Research, University of Maryland
AuthorAffiliation_xml – name: 1 Institute for Bioscience and Biotechnology Research, University of Maryland
Author_xml – sequence: 1
  givenname: Ryan D.
  surname: Heselpoth
  fullname: Heselpoth, Ryan D.
– sequence: 2
  givenname: Daniel C.
  surname: Nelson
  fullname: Nelson, Daniel C.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23169108$$D View this record in MEDLINE/PubMed
BookMark eNqFkU1LHTEUhoNY_P4LJQsXUrhtTjIzSTaC2msVbLuoxe5CbuZcb2Qm0SRXuf56Z1CLdtPVOXAeHl7es03WQwxIyC6wz0Jq-FJxaNbIFuiKTZiSf9bf7JtkO-cbxhrOarVBNrmARgNTW-TqiP7AB_rLJcTgwzX9jmURWzqPiZYF0q8-oSvY0ul97JbFx0DjnF4uMPUxFzvrkB7bAUg-dqviHZ2Gx1WPeZd8mNsu497L3CG_T6eXJ2eTi5_fzk-OLiauAigTLaXkXIJyUkDLKiVBoIYGOGtUwyqoa2ykdq62qAWCUrxtW8YECpy1mokdcvjsvV3OemwdhpJsZ26T721amWi9eX8JfmGu470R9dhFNQgOXgQp3i0xF9P77LDrbMC4zIbzWnBQmun_ogCq0aLS9Yh-fBvrb57X4gfg0zPgUsw54dw4X-zY75DSdwaYGb9qxq8O8P4_8KvvHfYEDHieQA
CitedBy_id crossref_primary_10_3389_fmicb_2016_00825
crossref_primary_10_7717_peerj_879
crossref_primary_10_1128_AEM_00446_16
crossref_primary_10_1016_j_biotechadv_2017_12_009
crossref_primary_10_1186_s12985_020_01403_0
crossref_primary_10_1128_AEM_00054_19
crossref_primary_10_1016_j_copbio_2015_10_005
crossref_primary_10_3390_v7062758
crossref_primary_10_3390_biom10010064
crossref_primary_10_1080_10408398_2019_1584874
ContentType Journal Article
Copyright Copyright © 2012, Journal of Visualized Experiments 2012
Copyright_xml – notice: Copyright © 2012, Journal of Visualized Experiments 2012
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
5PM
DOI 10.3791/4216
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList AGRICOLA

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
Engineering
EISSN 1940-087X
ExternalDocumentID PMC3520584
23169108
10_3791_4216
Genre Video-Audio Media
Research Support, U.S. Gov't, Non-P.H.S
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIGMS NIH HHS
  grantid: T32 GM080201
GroupedDBID ---
223
29L
53G
5GY
AAHBH
AAHTB
AAYXX
ABPEJ
ACGFO
ADBBV
AKRSQ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
CS3
DIK
E3Z
GX1
HYE
OK1
RPM
SJN
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
5PM
ID FETCH-LOGICAL-c411t-977722718c731d048713e91612068604155e679cc5ae93e1882ddd003e3ebd903
ISSN 1940-087X
IngestDate Thu Aug 21 14:18:01 EDT 2025
Fri Jul 11 13:11:24 EDT 2025
Fri Jul 11 04:01:40 EDT 2025
Thu Jan 02 22:16:32 EST 2025
Tue Jul 01 05:24:55 EDT 2025
Thu Apr 24 23:07:21 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 69
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c411t-977722718c731d048713e91612068604155e679cc5ae93e1882ddd003e3ebd903
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
Correspondence to: Daniel C. Nelson at nelsond@umd.edu
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC3520584
PMID 23169108
PQID 1186934959
PQPubID 23479
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3520584
proquest_miscellaneous_2253218909
proquest_miscellaneous_1186934959
pubmed_primary_23169108
crossref_citationtrail_10_3791_4216
crossref_primary_10_3791_4216
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20121107
PublicationDateYYYYMMDD 2012-11-07
PublicationDate_xml – month: 11
  year: 2012
  text: 20121107
  day: 7
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of visualized experiments
PublicationTitleAlternate J Vis Exp
PublicationYear 2012
Publisher MyJove Corporation
Publisher_xml – name: MyJove Corporation
References 18824123 - Curr Opin Microbiol. 2008 Oct;11(5):393-400
20144680 - Biochimie. 2010 May;92(5):507-13
10712737 - Biotechnol Bioeng. 2000 Apr 20;68(2):211-7
11577980 - Cell Mol Life Sci. 2001 Aug;58(9):1216-33
15972815 - J Biol Chem. 2005 Oct 7;280(40):34324-31
20003468 - Microb Cell Fact. 2009;8:66
14660638 - J Biol Chem. 2004 Mar 19;279(12):11495-502
16325201 - J Mol Biol. 2006 Jan 27;355(4):858-71
8454587 - J Biol Chem. 1993 Mar 25;268(9):6125-30
11259652 - Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):4107-12
11166567 - Trends Biochem Sci. 2001 Feb;26(2):100-6
17160051 - Nat Biotechnol. 2006 Dec;24(12):1508-11
18411226 - Protein Eng Des Sel. 2008 May;21(5):319-27
19474348 - Nucleic Acids Res. 2009 Jul;37(13):4472-81
18573077 - Annu Rev Biophys. 2008;37:153-73
2004447 - Clin Chem. 1991 Mar;37(3):398-402
16212665 - Microb Cell Fact. 2005 Oct 07;4:29
19454214 - Anal Biochem. 2009 May 1;388(1):71-80
16818874 - Proc Natl Acad Sci U S A. 2006 Jul 11;103(28):10765-70
15979390 - Curr Opin Microbiol. 2005 Aug;8(4):480-7
15857780 - Biomol Eng. 2005 Jun;22(1-3):21-30
15247237 - J Biol Chem. 2004 Oct 15;279(42):43697-707
References_xml – reference: 11166567 - Trends Biochem Sci. 2001 Feb;26(2):100-6
– reference: 17160051 - Nat Biotechnol. 2006 Dec;24(12):1508-11
– reference: 16818874 - Proc Natl Acad Sci U S A. 2006 Jul 11;103(28):10765-70
– reference: 11259652 - Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):4107-12
– reference: 15857780 - Biomol Eng. 2005 Jun;22(1-3):21-30
– reference: 15972815 - J Biol Chem. 2005 Oct 7;280(40):34324-31
– reference: 19474348 - Nucleic Acids Res. 2009 Jul;37(13):4472-81
– reference: 10712737 - Biotechnol Bioeng. 2000 Apr 20;68(2):211-7
– reference: 2004447 - Clin Chem. 1991 Mar;37(3):398-402
– reference: 15247237 - J Biol Chem. 2004 Oct 15;279(42):43697-707
– reference: 11577980 - Cell Mol Life Sci. 2001 Aug;58(9):1216-33
– reference: 20003468 - Microb Cell Fact. 2009;8:66
– reference: 15979390 - Curr Opin Microbiol. 2005 Aug;8(4):480-7
– reference: 18573077 - Annu Rev Biophys. 2008;37:153-73
– reference: 18411226 - Protein Eng Des Sel. 2008 May;21(5):319-27
– reference: 16325201 - J Mol Biol. 2006 Jan 27;355(4):858-71
– reference: 16212665 - Microb Cell Fact. 2005 Oct 07;4:29
– reference: 20144680 - Biochimie. 2010 May;92(5):507-13
– reference: 8454587 - J Biol Chem. 1993 Mar 25;268(9):6125-30
– reference: 14660638 - J Biol Chem. 2004 Mar 19;279(12):11495-502
– reference: 18824123 - Curr Opin Microbiol. 2008 Oct;11(5):393-400
– reference: 19454214 - Anal Biochem. 2009 May 1;388(1):71-80
SSID ssj0062058
Score 2.0627043
Snippet Directed evolution is defined as a method to harness natural selection in order to engineer proteins to acquire particular properties that are not associated...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
SubjectTerms anti-infective agents
bacteria
bacteriophages
cell walls
chemical bonding
chemical reactions
directed evolution
DNA-directed DNA polymerase
endolysin
Endopeptidases - chemistry
Endopeptidases - genetics
Endopeptidases - metabolism
engineering
enzyme kinetics
Enzyme Stability
equations
Escherichia coli - enzymology
Escherichia coli - genetics
Heating
Immunology
monitoring
mutagenesis
Mutagenesis, Site-Directed
natural selection
peptidoglycans
progeny
Recombinant Proteins - biosynthesis
Recombinant Proteins - chemistry
Recombinant Proteins - genetics
Recombinant Proteins - metabolism
screening
shelf life
Staphylococcus aureus
Streptococcus - enzymology
Streptococcus - genetics
Streptococcus pneumoniae
temperature
therapeutics
thermal stability
Transformation, Bacterial - genetics
virion
Title A New Screening Method for the Directed Evolution of Thermostable Bacteriolytic Enzymes
URI https://www.ncbi.nlm.nih.gov/pubmed/23169108
https://www.proquest.com/docview/1186934959
https://www.proquest.com/docview/2253218909
https://pubmed.ncbi.nlm.nih.gov/PMC3520584
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwGLVgCDQhIe4rMGQEbyhdbKex_VhGUYU0HmATe6vixBOTSjKt3aT213McJ27aFXF5iSLHTiwf-_P5nO9CyDuVqjOlYxWZTPMoYVZHWmY6So1JeCKUKmr_iqMv6fgk-Xw6OG0zZDfeJXPTz5db_Ur-B1WUAVfnJfsPyIaXogD3wBdXIIzrX2E8rM0Tv-XOdsap_Ed1OuhgOejFGRjl6LrphqOGmBiXPyuQQucz9cEHa66mCxe4dVQuF61HyE3Cen0-cx6YS7xwlRcgUPKxndnpReWPab4uIDY-9lcnzW1MSO_R_v6w3z1tYLx2u5MdAamdOaiq09tj_9hS5ueLz7-yKZ-F1E4-J5xtCX-9sS0FY0GoKa7dxLW6Te5w6ANxeyzjt9yUx3Ui1tCRe-R-87UD12qdc9xQJDbtYTsE4_ghedAMNB16mB-RW7Z8TO76XKGLJ-T7kAJsGsCmHmwKsCnApi3YNIBNqzPaBZuugU0bsJ-Sk0-j48Nx1GTFiPKEsTmWEgaAg1LkUrACAlgyYUHyGXfePi7iwsCmUuf5ILNaWAYVqigKCG8rrCl0LJ6RnbIq7R6hA56zTJqC29QkcYZlWxhjVZFLrXhieY-8bcdtkjch413mkumki0mP7IdaFz5EysbzN-2QTyC73A-prLTV1Qzap0q1gIquf18H-40ADdUx6jz3MIWvQDdJQXdVj8g1AEMFFzt9_Ul5_qOOoQ69A3MmefGHvr8ku6tV8IrszC-v7D5Y6Ny8rmfgL_5qilk
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+New+Screening+Method+for+the+Directed+Evolution+of+Thermostable+Bacteriolytic+Enzymes&rft.jtitle=Journal+of+visualized+experiments&rft.au=Heselpoth%2C+Ryan+D.&rft.au=Nelson%2C+Daniel+C.&rft.date=2012-11-07&rft.issn=1940-087X&rft.eissn=1940-087X&rft.issue=69&rft_id=info:doi/10.3791%2F4216&rft.externalDBID=n%2Fa&rft.externalDocID=10_3791_4216
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1940-087X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1940-087X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1940-087X&client=summon